Steven M. Lipkin, M.D., Ph.D., Associate Professor of Medicine, Division of Gastroenterology and Hepatology, has been named as Vice Chair for Basic and Translational Research in the Weill Department of Medicine. As Vice Chair for Basic and Translational Research, Dr. Lipkin will work closely with departmental and divisional leadership to enhance and foster the research activities of our faculty and trainees.
Dr. Steven Lipkin
A nationally and internationally regarded leader in the field of adult genetics, Dr. Lipkin was recently elected as a Member of the American Society of Clinical Investigation (ASCI). His research focuses on genetic testing for hereditary cancer disorders, including the Lynch Syndrome, Familial Adenomatous Polyposis, and Hereditary Pancreatic Cancer, among others. He is an authority on cancer genetic syndromes, with a particular emphasis on hereditary gastrointestinal cancer syndromes. Dr. Lipkin authored MAPP-MMR, a bioinformatic program that is used to interpret whether Lynch syndrome missense variants are deleterious mutations or benign polymorphisms, and he has more than 60 published papers in the top peer-reviewed journals. He is also author of The Genome Generation: Tales from the frontlines of Genetic Medicine, to be published in 2016 by Beacon Press.
Dr. Lipkin has practiced at New York-Presbyterian Hospital/Weill Cornell Medical College since 2009. He trained in Internal Medicine at Duke University and in Medical Genetics at the National Human Genome Research Institute, where he performed post-doctoral work in the laboratory of Francis Collins, now Director of the NIH. Dr. Lipkin is board certified in Clinical Genetics and is a fellow of the American Board of Medical Genetics and Genomics.